Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,089.71
+3.90
+0.36%
—1,085.811,083.231,092.001,074.08——
SIXC
Communications
SIXC
Communications
SIXC
+0.11%
608.36
+0.67
+0.11%
—607.69607.69609.89604.02——
SIXE
Energy
SIXE
Energy
SIXE
+0.14%
1,194.06
+1.68
+0.14%
—1,192.381,200.061,206.851,186.65——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.01%
1,756.14
-0.25
-0.01%
—1,756.391,753.531,760.321,733.52——
SIXM
Financials
SIXM
Financials
SIXM
-0.42%
630.60
-2.67
-0.42%
—633.27631.36633.90628.75——
SIXR
Staples
SIXR
Staples
SIXR
+0.07%
853.02
+0.60
+0.07%
—852.42853.25856.20850.72——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.05%
218.91
+0.12
+0.05%
—218.79218.79219.49217.26——
SIXT
Technology
SIXT
Technology
SIXT
+1.50%
3,767.41
+55.72
+1.50%
—3,711.693,719.293,776.213,699.88——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.39%
907.52
-3.53
-0.39%
—911.05909.99913.34902.56——
SIXV
Health care
SIXV
Health care
SIXV
+1.26%
1,519.55
+18.87
+1.26%
—1,500.661,504.161,526.631,504.16——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.12%
2,457.91
+2.95
+0.12%
—2,454.962,450.632,458.572,435.72——
ALMRY:OTCMKTS
ALMIRALL S A Unsponsored ADR
$14.07
0.00%
(0.00) 1D
Mar 2, 1:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALMRY...
Mkt. cap
2.54B
Avg. vol.
0.00
Volume
0.00
52-wk high
$15.56
52-wk low
$11.33
Beta
0.10
Shares outstanding
214.78M
No. of employees
2K
News stories
From sources across the web
Profile
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology. With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
About ALMIRALL S A Unsponsored ADR
CEOGianfranco Nazzi | Carlos Gallardo Piqué
Employees2.11K
Founded1944
Headquarters-
SectorPharmaceutical industry
Websitealmirall.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
277.27M
262.23M
288.93M
292.40M
Cost of goods sold
35.86M
157.74M
-27.67M
104.30M
Cost of revenue
35.86M
157.74M
-27.67M
104.30M
Research and development expenses
-35.50M
102.40M
-102.40M
34.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.95M
234.95M
-102.92M
121.60M
Operating expense
232.48M
81.32M
310.92M
158.10M
Total operating expenses
268.35M
239.05M
283.25M
262.40M
Operating income
8.92M
23.18M
5.69M
30.00M
Other non operating income
-3.90M
8.20M
3.36M
-1.70M
EBT including unusual items
8.33M
20.97M
9.35M
23.40M
EBT excluding unusual items
1.79M
29.41M
5.78M
24.50M
Income tax expense
3.35M
8.45M
2.29M
8.10M
Effective tax rate
40.20%
40.30%
24.54%
34.62%
Other operating expenses
182.66M
-179.66M
365.05M
1.70M
Net income
4.98M
12.52M
7.05M
15.30M
Net profit margin
1.80%
4.77%
2.44%
5.23%
Earnings per share
-
-
-
-
Interest and investment income
2.13M
1.37M
1.35M
1.00M
Interest expense
-4.21M
-3.89M
-5.05M
-4.50M
Net interest expenses
-2.08M
-2.52M
-3.70M
-3.50M
Depreciation and amortization charges
76.38M
-76.38M
151.18M
-
EBITDA
39.04M
69.66M
23.70M
67.50M
Gain or loss from assets sale
-
-
199.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer